ACHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Acadia Healthcare Company Inc (ACHC) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock shows weak financial performance, no significant positive catalysts, and mixed analyst ratings. Additionally, trading signals and technical indicators do not suggest a compelling entry point.
The MACD is below 0 and negatively contracting, indicating a bearish trend. RSI is neutral at 56.846, and moving averages are converging, showing no clear directional momentum. Key resistance levels are at 24.354 and 25.074, while support levels are at 22.024 and 21.304.
Analysts from UBS, RBC Capital, and Deutsche Bank have raised price targets and maintain Buy or Outperform ratings, citing operational improvements and achievable guidance.
Hedge funds are selling heavily, with a 194.77% increase in selling over the last quarter. The financials for Q4 2025 show a significant decline in net income (-3710.36% YoY) and EPS (-3820.00% YoY). No recent news or congress trading data is available to drive sentiment. Stock trend analysis predicts further declines in the short to medium term.
In Q4 2025, revenue increased by 6.10% YoY to $821.46M. However, net income dropped significantly to -$1.18B, and EPS fell to -13.02, reflecting severe financial challenges despite a stable gross margin.
Analyst ratings are mixed. While some firms like UBS and Deutsche Bank maintain Buy ratings with increased price targets, others like Jefferies downgraded the stock to Hold, citing operational headwinds and limited near-term catalysts.
